Clinical Trials Directory

Trials / Completed

CompletedNCT05437445

Utilizing Augmented Artificial Intelligence for Aminoacidopathies

Utilizing Augmented Artificial Intelligence for Aminoacidopathies: Experience of Collaborative Laboratory Integrated Reporting From Pakistan

Status
Completed
Phase
Study type
Observational
Enrollment
2,081 (actual)
Sponsor
Aga Khan University Hospital, Pakistan · Academic / Other
Sex
All
Age
1 Year – 16 Years
Healthy volunteers

Summary

The objective of the study was to interpret metabolic profiles of plasma amino acid (PAA) and compare reference intervals (RI) of PAA data from Pakistan with data from other countries using Clinical Laboratory Integrated Reports (CLIR). One-year data (reference and cases data) of twenty-two PAA, analyzed by ion exchange high performance chromatography at Biochemical Genetics Laboratory (BGL) of Aga Khan University Pakistan, was compiled in a comma-separated values (.csv) file and uploaded on CLIR Software using AAQP (Amino Acid in Plasma) application for statistical analysis. Among total of 2081 PAA profiles, 92% (n=1913) were completely normal with all PAA values falling within the age-specific reference range. A concordance of 98.8% was noted between the reporting done by the BGL at AKU and then after applying CLIR tools.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPlasma amino acid assayPlasma amino acid analysis was performed on all the blood samples received in biogenetics lab at Aga khan university, Karachi during one year period.

Timeline

Start date
2019-08-01
Primary completion
2020-08-30
Completion
2020-08-30
First posted
2022-06-29
Last updated
2022-07-05

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05437445. Inclusion in this directory is not an endorsement.